Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2912 results
A Cancer Grand Challenges graphic announcing 9 new challenges
  • Science & Technology
  • Health & Medicine

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

Two of our Cancer Awareness Nurses at a stop of our Cancer Awareness Roadshow

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

by Sophie Marshall | In depth | 2 March 2023

2 March 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023

In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton. In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton.

by Phil Prime | Podcast | 14 February 2023

14 February 2023

This entry is part 9 of 9 in the series Cancer Research Matters - series 1
%postcontent%
Glioblastoma cells seen through a microscope.

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

by Tim Gunn | Analysis | 13 February 2023

13 February 2023

Kizi, who was diagnosed with breast cancer, with some of the information leaflets he was given

Kizi and his wife Emma share the challenges they faced when he was diagnosed with a cancer that predominantly affects the opposite sex: a whirlwind of change and female-centred care. Kizi and his wife Emma share the challenges they faced when he was diagnosed with a cancer that predominantly affects the opposite sex: a whirlwind of change and female-centred care.

by Elisa Mitchell | Personal stories | 7 February 2023

7 February 2023

A black woman at a doctor's appointment

A new study has revealed that Black women from Caribbean and African backgrounds are more likely to be diagnosed with certain types of cancer at later stages, when treatment is less likely to be successful.  A new study has revealed that Black women from Caribbean and African backgrounds are more likely to be diagnosed with certain types of cancer at later stages, when treatment is less likely to be successful. 

by Jacob Smith | Analysis | 27 January 2023

27 January 2023

A busy London street.

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around. Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

by Tim Gunn | In depth | 24 January 2023

24 January 2023

A woman receiving chemotherapy from a nurse.

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded. Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

by Tim Gunn | News | 20 January 2023

20 January 2023

  • For Researchers

Time to get stratified

As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system. As genetic screening becomes routine for cancer detection and treatment, we need to ensure this can be delivered at scale and quickly within a national health system.

by Cancer Research UK | Analysis | 10 January 2023

10 January 2023